Clinical Trials

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced the initiation of a further Phase 3 trial (VLA2001-304) for its inactivated, adjuvanted COVID-19 vaccine...

AzurRx BioPharma, Inc., a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, announced the completion of site initiation visits and the addition of five (5) new clinical trial sites in Ukraine for the...

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced positive topline results from the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate,...

Eli Lilly and Company and Incyte announced results from an additional cohort of 101 adult patients from the COV-BARRIER trial. In this sub-study, patients with COVID-19 on mechanical ventilation or extracorporeal membrane oxygenation (ECMO) who received baricitinib plus standard...

Genoskin announces the launch of the ISR platform®, a new pre-clinical toolbox designed to study injection site reactions (ISR) in humans ahead of clinical trials. The company has filed intellectual property to protect its transformative platform worldwide. With the...

UPS Healthcare's clinical trial logistics unit, Marken, and THREAD, an innovative decentralized clinical trial technology provider, announced a partnership to bring the first ever, unified, decentralized clinical trial solution into patients' homes. The combined offering brings together THREAD's digital...

Alvotech, the Iceland-based biosimilar company, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04, Alvotech's proposed biosimilar to the reference product Stelara®. The objective of the study is...